Literature DB >> 22083507

A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosis.

Paola Siri1, Eric Henninger, Maria Pia Sormani.   

Abstract

In this article, we propose a parametric model for the distribution of time to first event when events are overdispersed and can be properly fitted by a Negative Binomial distribution. This is a very common situation in medical statistics, when the occurrence of events is summarized as a count for each patient and the simple Poisson model is not adequate to account for overdispersion of data. In this situation, studying the time of occurrence of the first event can be of interest. From the Negative Binomial distribution of counts, we derive a new parametric model for time to first event and apply it to fit the distribution of time to first relapse in multiple sclerosis (MS). We develop the regression model with methods for covariate estimation. We show that, as the Negative Binomial model properly fits relapse counts data, this new model matches quite perfectly the distribution of time to first relapse, as tested in two large datasets of MS patients. Finally we compare its performance, when fitting time to first relapse in MS, with other models widely used in survival analysis (the semiparametric Cox model and the parametric exponential, Weibull, log-logistic and log-normal models).

Entities:  

Mesh:

Year:  2011        PMID: 22083507     DOI: 10.1007/s10985-011-9207-z

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  10 in total

1.  Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.

Authors: 
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

2.  Estimating the variance of standardized rates of recurrent events, with application to hospitalizations among the elderly in New England.

Authors:  R J Glynn; T A Stukel; S M Sharp; T A Bubolz; J L Freeman; E S Fisher
Journal:  Am J Epidemiol       Date:  1993-04-01       Impact factor: 4.897

3.  Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.

Authors: 
Journal:  Lancet       Date:  1998-11-07       Impact factor: 79.321

4.  Statistical methods for the analysis of relapse data in MS clinical trials.

Authors:  Y C Wang; L Meyerson; Y Q Tang; N Qian
Journal:  J Neurol Sci       Date:  2009-08-25       Impact factor: 3.181

5.  The distribution of new enhancing lesion counts in multiple sclerosis: further explorations.

Authors:  Ij van den Elskamp; Dl Knol; Bmj Uitdehaag; F Barkhof
Journal:  Mult Scler       Date:  2008-10-09       Impact factor: 6.312

6.  Comparison of statistical approaches to evaluate factors associated with metabolic syndrome.

Authors:  Desta Fekedulegn; Michael Andrew; John Violanti; Tara Hartley; Luenda Charles; Cecil Burchfiel
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-05       Impact factor: 3.738

7.  Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials.

Authors:  M P Sormani; P Bruzzi; D H Miller; C Gasperini; F Barkhof; M Filippi
Journal:  J Neurol Sci       Date:  1999-02-01       Impact factor: 3.181

8.  Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets.

Authors:  M P Sormani; D H Miller; G Comi; F Barkhof; M Rovaris; P Bruzzi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

9.  Differential expression analysis for sequence count data.

Authors:  Simon Anders; Wolfgang Huber
Journal:  Genome Biol       Date:  2010-10-27       Impact factor: 13.583

10.  Modelling new enhancing MRI lesion counts in multiple sclerosis.

Authors:  M P Sorman; P Bruzzi; M Rovaris; F Barkhof; G Comi; D H Miller; G R Cutter; M Filipp
Journal:  Mult Scler       Date:  2001-10       Impact factor: 6.312

  10 in total
  1 in total

1.  Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.

Authors:  Leonard H Verhey; Alessio Signori; Douglas L Arnold; Amit Bar-Or; A Dessa Sadovnick; Ruth Ann Marrie; Brenda Banwell; Maria Pia Sormani
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.